Press Release
November 9, 2026
CINCINNATI, OH — November 9, 2026 — Relevate Health® is the data-driven, AI-enabled omnichannel activation platform for life sciences commercialization, activating OMNI KNOW-HOW® to connect pharma brands with clinicians at the Point-of-Learning and Point-of-Clinical-Decision. Today, Relevate Health announced an exclusive co-developed precision messaging capability designed to drive script lift with Flora Health™ a healthcare technology company that connects media, patient access, and commercial intelligence within point-of-care and health system workflows.
The new capability uses signals from existing brand interactions, together with defined business rules, combining Relevate Health's ELE Decision Engine® and omnichannel HCP intelligence to inform where in the electronic health record (EHR) workflow a contextually relevant message is most impactful in supporting HCPs at the Point-of-Clinical-Decision.
Connecting Omnichannel Engagement to Precision EHR Messaging
Pharmaceutical brands engage HCPs across an increasingly complex mix of channels, but those experiences are often planned and measured independently. The co-developed precision messaging capability closes that gap. Omnichannel signals and clinical triggers are combined through Relevate Health's Precise Business Rules methodology to define individual-level HCP EHR targeting. Flora Health’s point-of-care capabilities, EHR connectivity, and targeting capabilities enable delivery of eligible messages within the HCP’s existing clinical workflow.
“Relevate’s approach to defining and designing the right audience has always been a key advantage, and with the development of their Precise Business Rule scoring and ELE Decision Engine, they’re now able to simplify targeting rather than adding complexity,” said John Michael Skoyles, Executive Vice President, Growth, Flora Health. “By connecting Relevate Health’s engagement intelligence with Flora Health’s point of care and clinical workflow capabilities, we can help brands bring greater context and relevance into the moments when HCPs are making decisions.”
For pharmaceutical brands, this delivers more precise EHR targeting and stronger connectivity with HCPs across their marketing channel ecosystem. For HCPs, it provides an opportunity to receive relevant, compliant information within their existing clinical workflow and consistent reinforcement across channels outside the EHR.
"What matters most is timing, context, and relevance at the point of clinical decision," said George Karyotakis, SVP, Strategic Solutions. "This exclusive capability helps brands reach the right HCP with the right message at the right clinical moment, and that relevancy drives enhanced brand utilization. We’ve seen script lift with brands using precision messaging of almost double general NPI targeting. "
Precision Within the EHR: Compliant by Design
At the core of this offering is the Precise Business Rule methodology, a framework of contextually relevant business rules evaluated using standardized, structured EHR data fields, including ICD-10, NDC, and CPT codes, to determine message eligibility. By moving beyond NPI matching and layering multiple clinical codes at the same time, brands can achieve greater specificity in reaching the HCPs they are targeting. These criteria are assessed entirely within the EHR environment and triggered in real time.
The messaging process does not require extracting, storing, or transmitting patient-identifiable information to the pharmaceutical manufacturer. MLR-approved business rules apply to structured EHR data to determine whether the predefined criteria for a given message are met. The output is an eligibility determination message, creating a privacy safeguard built into the model's architecture.
The capability is designed to support HCP decision-making, not replace clinical judgment. It can support a range of pharmaceutical brand objectives—including disease awareness, treatment consideration, patient identification, and access and affordability communications—within brand-approved, FDA-labeling-aligned business rules.
Redefining the EHR as a Precision Engagement Channel
The EHR is not simply another media environment. It is a high-value moment to connect engagement across the full clinical workflow and drive measurable script impact.
This co-developed precision messaging capability is available exclusively through Relevate Health. It is the only solution combining Relevate Health's ELE Decision Engine and omnichannel HCP intelligence with Flora Health's clinical workflow delivery to drive script lift at the Point-of-Clinical-Decision.